BCTX (STOCKS)
Briacell Therapeutics Corp. Common Shares
$4.210000
-0.030000 (-0.71%)
Prev close: $4.240000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- William V. Williams
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $26.55M
- Employees
- 4
- P/E (TTM)
- -0.09
- P/B (TTM)
- 0.80
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $261.44K |
| Operating Expenses | $30.37M |
| Research and Development | $24.29M |
| Other Operating Expenses | $6.17M |
| Operating Income/Loss | -$30.37M |
| Income/Loss Before Equity Method Investments | $24.30M |
| Income/Loss From Continuing Operations After Tax | $24.11M |
| Income/Loss From Continuing Operations Before Tax | $24.11M |
| Income/Loss From Equity Method Investments | -$197.53K |
| Net Income/Loss | -$29.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$297.94K |
| Net Income/Loss Attributable To Parent | -$28.71M |
| Net Income/Loss Available To Common Stockholders, Basic | -$28.71M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$63.81 |
| Diluted Earnings Per Share | -$63.81 |
| Basic Average Shares | 6,024,176 |
| Diluted Average Shares | 6,024,176 |
| Assets | $13.08M |
| Current Assets | $11.35M |
| Noncurrent Assets | $1.73M |
| Fixed Assets | $273.98K |
| Intangible Assets | $180.71K |
| Non-current Prepaid Expenses | $717.51K |
| Other Non-current Assets | $554.45K |
| Liabilities | $3.72M |
| Current Liabilities | $3.32M |
| Noncurrent Liabilities | $406.87K |
| Equity | $9.35M |
| Equity Attributable To Noncontrolling Interest | -$627.56K |
| Equity Attributable To Parent | $9.98M |
| Liabilities And Equity | $13.08M |
| Net Cash Flow From Operating Activities | -$28.92M |
| Net Cash Flow From Operating Activities, Continuing | -$28.92M |
| Net Cash Flow From Investing Activities | -$7.65M |
| Net Cash Flow From Investing Activities, Continuing | -$7.65M |
| Net Cash Flow From Financing Activities | $46.20M |
| Net Cash Flow From Financing Activities, Continuing | $46.20M |
| Net Cash Flow | $9.63M |
| Net Cash Flow, Continuing | $9.63M |
| Comprehensive Income/Loss | -$29.01M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$29.01M |
| Other Comprehensive Income/Loss | $0.00 |